reference/12585981

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12585981

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	423
issn	1531-8249 0364-5134
issueIdentifier	3
pageRange	416-423
publicationName	Annals of Neurology
startingPage	416
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6701c569eef2395413bcbe7b5831e68b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7e4093e67e07c4ab9c05114c86491c3a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5174f064cb889baad62bcb728566b833
bibliographicCitation	Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ; HNRC Group. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol. 2004 Sep;56(3):416–23. doi: 10.1002/ana.20198. PMID: 15349869.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b04325025f5fb989122173ec7cd58738 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11ec7200fd3f05d61d67aae6b377cf15 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b255ee26379e57adc3b2c5341c7dc0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_697c23827337baf19a2dcb8002e52b4b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e11f467059a16bfe0b8b3eb4c521102d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c085ec74b01a71c0180ced176616b256 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_726b7d86c88af65656aeaa0b615415f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3fb4326c8e8046db6884559219044c8
date	2004-08-31^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/ana.20198 https://pubmed.ncbi.nlm.nih.gov/15349869
isPartOf	https://portal.issn.org/resource/ISSN/0364-5134 https://portal.issn.org/resource/ISSN/1531-8249 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/656
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
discusses	http://id.nlm.nih.gov/mesh/M0446823
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015497Q000187 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D044966Q000627 http://id.nlm.nih.gov/mesh/D003072Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015658Q000523 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D015497Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D003072Q000523 http://id.nlm.nih.gov/mesh/D016009 http://id.nlm.nih.gov/mesh/D044966Q000494 http://id.nlm.nih.gov/mesh/D003072Q000134 http://id.nlm.nih.gov/mesh/D018709 http://id.nlm.nih.gov/mesh/D009483Q000706 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10419 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385

Showing number of triples: 1 to 54 of 54.